Clinicopathologic characteristics, therapy and outcomes of gastroenteropancreatic neuroendocrine tumours: A single-centre experience

#4391

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are tumours derived from neuroendocrine cells that can occur anywhere along the gastrointestinal tract and comprise a heterogeneous family of neoplasms with a wide and complex spectrum of clinical behaviour.

Aim(s): Analyse the clinicopathologic, therapeutic, and survival features of patients with GEP-NETs.

Materials and methods: We performed a retrospective data analysis of patients with GEP-NETs admitted to the medical oncology department of University Hospital Center of Oran between 2010 and 2023.

Conference:

Presenting Author:

Authors: Behourah Z, Ahed Messaoud M, Hamidatou K, Megaiz A, Lechar M,

Keywords: Gastroenteropancreatic neuroendocrine tumour, Functional neuroendocrine tumour, Somatostatin analogue (SSA), Chemotherapy,